Announcement time of this financial report: 2023-10-25 18:24:35
* ST Megu (Stock Code: 000615) is a company operating in the bio-based fiber and medical beauty industries. In the bio-based fiber industry, the company focuses on R & D and production of green fiber, including Lessel fiber and viscose filament. In the medical beauty industry, the company participates in the development and sales of medical beauty projects and products. Overall, * ST Meigu has a certain market position and development potential in the bio-based fiber and medical beauty industry.
In terms of assets and liabilities, * ST's total assets in the third quarter of 2023 were 3.628 billion yuan, down from 3.76 billion yuan at the end of the previous year. The total debt was 3.462 billion yuan, down from 3.53 billion yuan at the end of last year. The company's net worth was 166 million yuan, down from 230 million yuan at the end of last year. The asset-liability ratio was 95.42%, up from 93.88% at the end of the previous year.
In terms of profit, the company's operating income in the third quarter of 2023 was 1.042 billion yuan, down from 1.091 billion yuan in the same period last year. The operating cost was 743 million yuan, down from 841 million yuan in the same period last year. The gross profit margin was 28.66%, up from 22.9% in the same period last year. This is mainly due to the business growth of the medical and beauty sector in this period.
In terms of cash flow, the net cash flow generated by operating activities was 161 million yuan, a substantial increase from-7.8027 million yuan in the same period last year. Cash inflow from operating activities totaled 1.108 billion yuan, down from 1.253 billion yuan in the same period last year. Cash outflow from operating activities totaled 948 million yuan, down from 1.26 billion yuan in the same period last year. This is mainly through the advance collection of medical funds by the medical and cosmetic division and the acceleration of collection by the bio-based fiber division, which improves the net inflow of operating cash flow.
To sum up, * ST Meigu's business situation was generally stable in the third quarter of 2023. Although the total assets and net assets of the company have decreased, the liabilities have also decreased and the asset-liability ratio has increased. In terms of profit, although the company's operating income has decreased, the reduction of operating costs and the growth of medical and beauty business have increased the company's gross profit margin. In terms of cash flow, the net cash flow generated by the company's operating activities has increased significantly, indicating an improvement in the company's cash flow.
For investors, * ST Meigu has a certain market position and development potential in both bio-based fiber and medical beauty industry. Although the total assets and net assets of the company have decreased, the liabilities have also decreased and the asset-liability ratio has increased. In terms of profit, although the company's operating income has decreased, the reduction of operating costs and the growth of medical and beauty business have increased the company's gross profit margin. In terms of cash flow, the net cash flow generated by the company's operating activities has increased significantly, indicating an improvement in the company's cash flow. Therefore, investors can properly pay attention to the follow-up development of * ST Meigu.
This article only represents the judgment made by the analyst himself or the analyst on the basis of AI analysis, and can not be used as any investment index, nor does it constitute any investment advice. The original intention of this paper is to help investors analyze and judge the capital market data in the most intuitive and fast way and from the most professional perspective.